menu search

Xencor: a mid-stage clinical company with falling losses

Xencor, Inc. is a biotech company focused on the development and commercialization of anticancer medications. They have successful partnerships and li...

October 20, 2023, 11:02 pm

Allyx therapeutics to present phase 1 data for lead compound alx-001 at the 16th clinical trials on alzheimer’s disease meeting

Allyx’s lead compound, ALX-001, is a small molecule with unique mechanism of action at mGluR5, to pro...

October 19, 2023, 8:05 pm

Terns pharmaceuticals to participate in upcoming investor conferences

FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...

October 19, 2023, 8:05 pm

Transplant diagnostics market surges at 7.2% cagr towards usd 8.3 billion by 2032 | market.us

In 2022, molecular assays led in technology, reagents topped product & service, solid organ transplants...

October 19, 2023, 1:52 pm

Clarkson university researchers awarded nysp2i grant to develop sustainable food packaging and present at “keep it fresh!” symposium

POTSDAM, NY, Oct. 18, 2023 (GLOBE NEWSWIRE) — Silvana Andreescu, Egon Matijević Endowed Chair of Chemistry and Bio...

October 18, 2023, 5:13 pm

Here's why you should retain qiagen (qgen) stock for now

Investors are optimistic about QIAGEN's (QGEN) growth in the molecular diagnostics business and the lat...

October 18, 2023, 12:02 pm

Interactive brokers group, inc. (ibkr) q3 2023 earnings call transcript

Interactive Brokers Group, Inc. (NASDAQ:IBKR ) Q3 2023 Earnings Call Transcript October 17, 2023 4:30 PM ET Company Participants Nancy Stuebe - Direct...

October 17, 2023, 7:50 pm

Shareholder alert: robbins llp informs shareholders of class action filed against dermtech, inc. (dmtk)

SAN DIEGO, Oct. 16, 2023 (GLOBE NEWSWIRE) — Robbins LLP informs investors that a shareholder filed a class action lawsuit on behalf of persons and e...

October 17, 2023, 3:05 am

Biontech to present multiple program updates across modalities at esmo congress 2023

MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, c...

October 16, 2023, 3:30 am

Coherus announces toripalimab data at 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

— Data demonstrate preclinical potent T cell activation and differentiated mechanism of action and enhanced clinical efficacy irrespective of PD-L1 ...

October 14, 2023, 4:30 pm

Cogent biosciences presents preclinical data highlighting precision oncology pipeline at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

– Novel selective and reversible FGFR2 inhibitor exhibits strong potency across key primary and resistance driver mutations with potential advantage...

October 14, 2023, 4:30 pm

Prelude announces multiple clinical and preclinical poster presentations at aacr-nci-eortc international conference 

WILMINGTON, Del. and BOSTON, Oct. 14, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD), a clinical-stage pre...

October 14, 2023, 4:30 pm

Olema oncology kat6 inhibitor compounds demonstrate potent anti-tumor activity

Preclinical data to be presented at the 2023 AACR-NCI-EORTC International Conference on molecular Targe...

October 12, 2023, 11:01 am

Peter madrid, head of scientific discovery at synfini, joins other expert speakers to lead a national academies of sciences workshop on ai for scientific discovery 

MENLO PARK, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) — Synfini, Inc., a pioneer in agile chemistry whose advanced, automated ...

October 11, 2023, 6:29 pm

Nautilus biotechnology to announce third quarter financial results on october 31, 2023

SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-...

October 11, 2023, 12:05 pm

Pmv pharmaceuticals to present updated phase 1 data on pc14586 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics and host a kol webinar

PRINCETON, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery an...

October 11, 2023, 12:00 pm

Phio pharmaceuticals presents new data for targeting of brd4 with its intasyl™ compound ph-894

–Preclinical data shows melanoma cells treated with PH-894 makes them more recognizable to immune cells, increasing potential for elimination –Pre...

October 11, 2023, 11:30 am

Nautilus biotechnology to announce third quarter financial results on october 31, 2023

SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-...

October 11, 2023, 8:05 am

Why is nucana (ncna) stock down today?

NuCana (NASDAQ: NCNA ) stock is sliding lower on Tuesday as the clinical-stage biopharmaceutical company prepares for a presentation this week. NuCan...

October 10, 2023, 8:46 am

Ocuphire pharma to present at euretina and retina society conferences in october

Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy FARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE NEWSWIRE) �...

October 6, 2023, 12:00 pm


Search within

Pages Search Results: